159 related articles for article (PubMed ID: 30601995)
1. Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest.
Newell M; Brun M; Field CJ
J Nutr; 2019 Jan; 149(1):46-56. PubMed ID: 30601995
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic Acid Incorporation Is Not Affected by Doxorubicin Chemotherapy in either Whole Cell or Lipid Raft Phospholipids of Breast Cancer Cells in vitro and Tumor Phospholipids in vivo.
Newell M; Patel D; Goruk S; Field CJ
Lipids; 2020 Sep; 55(5):549-565. PubMed ID: 32588470
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
[TBL] [Abstract][Full Text] [Related]
4. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
Lee MG; Lee KS; Nam KS
IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
[TBL] [Abstract][Full Text] [Related]
5. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.
Rahman MM; Veigas JM; Williams PJ; Fernandes G
Breast Cancer Res Treat; 2013 Oct; 141(3):341-52. PubMed ID: 24062211
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
[TBL] [Abstract][Full Text] [Related]
7. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
Yang T; Xiao Y; Liu S; Luo F; Tang D; Yu Y; Xie Y
Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
[TBL] [Abstract][Full Text] [Related]
8. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.
Ewaschuk JB; Newell M; Field CJ
Lipids; 2012 Nov; 47(11):1019-30. PubMed ID: 23054549
[TBL] [Abstract][Full Text] [Related]
9. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice.
Connolly JM; Gilhooly EM; Rose DP
Nutr Cancer; 1999; 35(1):44-9. PubMed ID: 10624705
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
[TBL] [Abstract][Full Text] [Related]
11. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
Newell M; Goruk S; Mazurak V; Postovit L; Field CJ
Breast Cancer Res Treat; 2019 Sep; 177(2):357-367. PubMed ID: 31236812
[TBL] [Abstract][Full Text] [Related]
12. Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmaileh B; Mansour Al Shhab MA; Al-Ameer HJ; Mustafa E
J Physiol Pharmacol; 2021 Apr; 72(2):. PubMed ID: 34374660
[TBL] [Abstract][Full Text] [Related]
13. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic Acid, a Key Compound for Enhancing Sensitization to Drug in Doxorubicin-Resistant MCF-7 Cell Line.
Crovella S; Ouhtit A; Rahman SM; Rahman MM
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049499
[TBL] [Abstract][Full Text] [Related]
15. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
Ottewell PD; Mönkkönen H; Jones M; Lefley DV; Coleman RE; Holen I
J Natl Cancer Inst; 2008 Aug; 100(16):1167-78. PubMed ID: 18695136
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.
Elieh Ali Komi D; Shekari N; Soofian-Kordkandi P; Javadian M; Shanehbandi D; Baradaran B; Kazemi T
Clin Nutr ESPEN; 2021 Dec; 46():477-483. PubMed ID: 34857238
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells.
Fernando W; Coombs MRP; Hoskin DW; Rupasinghe HPV
Carcinogenesis; 2016 Oct; 37(10):1004-1013. PubMed ID: 27535497
[TBL] [Abstract][Full Text] [Related]
19. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
[TBL] [Abstract][Full Text] [Related]
20. Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana.
Yuan C; Wang C; Wang J; Kumar V; Anwar F; Xiao F; Mushtaq G; Liu Y; Kamal MA; Yuan D
Nutr Res; 2016 Nov; 36(11):1243-1254. PubMed ID: 27865619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
